Clinical Roundup Itismeran autogene + Keytruda demonstrated improvement in recurrence-free survival in neoadjuvant melanoma January 30, 2026Vol.52 No.04
Clinical Roundup Lab-grown organoids reveal how glioblastoma resists treatment January 30, 2026Vol.52 No.04
Clinical Roundup Oral bacterium may promote breast cancer development and spread, Hopkins study finds January 30, 2026Vol.52 No.04
Clinical Roundup UTSW researchers boost the power of CAR T cells to fight cancer January 30, 2026Vol.52 No.04
Clinical Roundup UCLA launches trial comparing two types of PSMA radiopharmaceuticals for recurrent prostate cancer January 30, 2026Vol.52 No.04
Clinical Roundup Most patients support use of AI to help read mammograms with doctor oversight, UTSW survey finds January 30, 2026Vol.52 No.04
Drugs & Targets FDA approves Darzalex Faspro as quad regimen for all newly diagnosed MM January 30, 2026Vol.52 No.04
Drugs & Targets Trodelvy added to NCCN guidelines as preferred regimen option for first-line metastatic TNBC January 30, 2026Vol.52 No.04
Drugs & Targets Labcorp and Roche collaborate to expand access to advanced precision testing January 30, 2026Vol.52 No.04
